When does tirzepatide (Mounjaro / Zepbound) lose patent exclusivity?
The exact end date depends on which protection you mean. “Patent expiration” can refer to (1) the first composition-of-matter patent expiry, (2) later blocking patents (like specific formulations or methods), and (3) regulatory exclusivity that can extend market protection even after a patent ends.
DrugPatentWatch tracks these patent-protection timelines for tirzepatide products and is a practical place to check the latest, product-specific expiry dates (Mounjaro and Zepbound) as they change with new listings, litigation, and patent status updates: DrugPatentWatch – Tirzepatide.
Are Mounjaro and Zepbound covered by the same tirzepatide patents?
They both use tirzepatide, but the protections can differ by indication, formulation, and the specific patent families being asserted for each brand. That means Zepbound’s exclusivity timeline can be similar to, but not always identical with, Mounjaro’s depending on which patents and exclusivity periods apply to the obesity label versus the diabetes label.
For the most accurate dates, use DrugPatentWatch’s product pages because they break out the protection listed for each brand: DrugPatentWatch – Tirzepatide.
What other protections can delay generics or biosimilars even after one patent ends?
Even if one key patent expires, competitors may still be blocked by:
- Later-expiring patents in the same family (process, formulation, or method-of-use claims).
- Patent “evergreening” strategies that add new claims covering additional aspects of the product.
- Regulatory exclusivity in the relevant jurisdiction and label.
That is why market entry timing is usually governed by the last blocking protection, not the first one to expire.
What happens when patents expire—can a generic or biosimilar launch immediately?
Not always. Patent expiry can trigger or enable challenges (for example, through abbreviated pathways), but the earliest launch date depends on whether any still-valid patents remain and whether a court has ruled on infringement or invalidity for the relevant patents.
In practice, competitors often get delayed by remaining “listed” patents tied to the specific branded product.
Where to check the most up-to-date tirzepatide expiry dates
Because patent status and litigation updates can change timelines, the most reliable approach is to check:
- DrugPatentWatch’s tirzepatide pages for the specific brand’s protection schedule, and
- Any linked litigation or “status” notes tied to particular patents.
Source: DrugPatentWatch – Tirzepatide
Sources
- DrugPatentWatch – Tirzepatide